DENKHAUS DONALD A — SEC Form 4 filings
SEC reporting owner CIK 1278439. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-06 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | 11 | — | — | 33 |
Form 4 filings — DENKHAUS DONALD A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to issuer (D): 498,773 @ $31.50 · Disposition to issuer (D): 33,500 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 29,524 (derivative) @ $0 · +5 more | EDGAR |
| 2025-12-30 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 947 · Grant/award (A): 18,115 (derivative) @ $0 · Grant/award (A): 5,468 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 50,000 @ $2.24 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,333 · Option exercise (M): 1,333 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/award (A): 23,248 (derivative) @ $0 · Grant/award (A): 2,841 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 40,000 @ $4.01 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1278439 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →